SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-023916
Filing Date
2020-12-18
Accepted
2020-12-18 15:54:56
Documents
10
Period of Report
2020-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 42944
2 ex5-1.htm EX-5.1 19725
3 ex10-1.htm EX-10.1 248391
4 ex10-2.htm EX-10.2 61365
5 ex10-3.htm EX-10.3 109548
6 ex10-4.htm EX-10.4 111761
7 ex10-5.htm EX-10.5 113472
8 ex99-1.htm EX-99.1 13831
9 ex5-1_001.jpg GRAPHIC 4344
10 ex99-1_001.jpg GRAPHIC 3532
  Complete submission text file 0001493152-20-023916.txt   733400
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 201400550
SIC: 2834 Pharmaceutical Preparations